Clinical Trial Update: Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating nivolumab with chemoradiotherapy for muscle-invasive bladder cancer in patients not undergoing cystectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Hellenic GenitoUrinary Cancer Group | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN